Normative Values of the Nasal Obstruction Symptom Evaluation Scale

Facial Plast Surg Aesthet Med. 2023 Jan-Feb;25(1):35-39. doi: 10.1089/fpsam.2021.0303. Epub 2022 May 20.

Abstract

Background: The Nasal Obstruction Symptom Evaluation (NOSE) scale is widely used by clinicians in evaluation of nasal airway obstruction (NAO). Objective: To determine normative values for the NOSE scale among both symptomatic and asymptomatic members of the general U.S. population. Methods: A survey of NAO symptoms in adults of age 18 years and older was performed. The distribution of NOSE scores among the general population was estimated. Influence of features including age, gender, race, location, and symptomatology on NOSE scores was evaluated. Results: Surveys were completed by 2333 participants. Mean NOSE score was 11 (standard deviation [SD] 11) in the asymptomatic, and 28 (SD 22) in the symptomatic population (p < 0.0001). Increasing age was associated with an increase in scores until 45 years, after which it was associated with decreasing scores. No significant differences were found related to other investigated demographics. Conclusions: Normative ranges for the NOSE scale are established, and are largely consistent with values in the existing literature. NOSE scores do not appear to be influenced by gender, race, or geography, although age should be considered in their interpretation.

Publication types

  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Humans
  • Middle Aged
  • Nasal Obstruction* / diagnosis
  • Surveys and Questionnaires
  • Symptom Assessment